Intrinsic Value of S&P & Nasdaq Contact Us

Dyadic International, Inc. DYAI NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
40/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$3.00
+244.8%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Dyadic International, Inc. (DYAI) has a negative trailing P/E of -4.2, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 87.0 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -23.79%, forward earnings yield 1.15%. PEG 0.22 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.22); analyst target implies upside (+244.8%).
  • Forward P/E 87.0 — analysts expect a return to profitability with estimated EPS of $0.01 for FY2027.
  • PEG Ratio 0.22 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -23.79% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 1.15% as earnings recover.
  • Analyst consensus target $3.00 (+244.8% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 40/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
40/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
64/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
MOAT
20/100
→ Income
~
GROWTH
55/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — DYAI

Valuation Multiples
P/E (TTM)-4.2
Forward P/E87.0
PEG Ratio0.22
Forward PEG0.22
P/B Ratio25.12
P/S Ratio11.19
EV/EBITDA-4.9
Per Share Data
EPS (TTM)$-0.23
Forward EPS (Est.)$0.01
Book Value / Share$0.04
Revenue / Share$0.09
FCF / Share$-0.17
Yields & Fair Value
Earnings Yield-23.79%
Forward Earnings Yield1.15%
Dividend Yield0.00%
Analyst Target$3.00 (+244.8%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 -16.8 0.16 1.05 102.30 -
2017 -19.0 0.75 0.81 53.38 -
2018 -9.2 -0.05 1.23 40.37 -
2019 -16.8 -0.35 3.90 83.21 -
2020 -15.8 -1.64 5.20 92.26 -
2021 -9.6 -0.25 6.84 52.34 -
2022 -3.6 0.13 3.15 11.91 -
2023 -6.8 0.23 7.89 15.99 -
2024 -8.8 0.53 20.77 14.68 -
2025 -4.2 -0.28 24.88 9.92 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $-0.10 $592.89K $-3.61M -608.7%
2017 $-0.07 $758.42K $-2.14M -281.6%
2018 $-0.21 $1.3M $-5.69M -439.4%
2019 $-0.31 $1.68M $-8.31M -494.2%
2020 $-0.34 $1.6M $-9.33M -582.1%
2021 $-0.46 $2.4M $-12.92M -537.5%
2022 $-0.33 $2.93M $-9.37M -319.8%
2023 $-0.24 $2.9M $-6.8M -234.4%
2024 $-0.20 $3.5M $-5.81M -166.2%
2025 $-0.23 $3.09M $-7.36M -238.3%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.06 $-0.08 – $-0.04 $8.47M $6.26M – $10.57M 2
2027 $0.18 $0.12 – $0.24 $20.01M $14.79M – $24.95M 2
2028 $0.24 $0.16 – $0.32 $19.67M $14.54M – $24.53M 1
2029 $0.24 $0.16 – $0.32 $19.74M $14.59M – $24.61M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message